We describe how molecular diagnosis of a rare, fatal neurodegenerative condition led to the rational design, testing, and manufacture of milasen, a splice-modulating antisense oligonucleotide drug tailored to a particular patient.
albuterol hfa coupon (Funded by the Canadian Institutes of Health Research and others;
